US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

445 deals · US$333bndisclosed · Healthcare · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Apr 2026 Exclusive global rights to TAK-063 (balipodect) Takeda Pharmaceutical Co.Axsome TherapeuticsAsset saleCompleted–Pharma+1 Sidley Austin (buy-side)
Apr 2026 Forian –Max WygodAcquisitionAnnounced68.0Healthcare Software+1 Houlihan Lokey (sell-side)Potter Anderson & Corroon (sell-side)Miles & Stockbridge (sell-side)Duane Morris (sell-side)A&O Shearman (buy-side)Abrams & Bayliss (buy-side)Venable (buy-side)
Apr 2026 EpiVax –SV Health InvestorsAcquisitionAnnounced–Pharma Services+2 Morgan Lewis (buy-side)
Apr 2026 View Point Medical –Merit Medical SystemsAcquisitionCompleted140.0Medtech+1 Piper Sandler (buy-side)Baker McKenzie (buy-side)
Apr 2026 HLSG Intermediate ––AcquisitionAnnounced–Healthcare Services+1 Latham & Watkins (buy-side)
Apr 2026 Cumberland U.S. branded businesses Cumberland PharmaceuticalsApotexAsset saleAnnounced–Pharma Kirkland & Ellis (buy-side)
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleAnnounced1,075.0Diagnostics+1 Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side)
Apr 2026 IntusCare –Blue Star Innovation PartnersAcquisitionAnnounced–Healthcare Software+1 Kirkland & Ellis (buy-side)
Apr 2026 Faithful Companion –Freedom 3 CapitalStakeCompleted–Healthcare Services William Blair
Apr 2026 McKesson Medical-Surgical Solutions (MMS) business McKessonFunds managed by affiliates of ApolloStakePending1,250.0Distribution+1 Davis Polk (sell-side)Latham & Watkins (buy-side)
Apr 2026 Midwest Products & Engineering –Graham PartnersAcquisitionCompleted–Medtech+1 Kirkland & Ellis (sell-side)Baird (sell-side)Dechert (buy-side)
Apr 2026 Surgistar –HalmaAcquisitionCompleted–Medtech Baird (sell-side)
Apr 2026 Modeyso commercial sales royalties Former Oncoceutics Inc. securityholdersHealthCare RoyaltyAsset saleAnnounced–Specialty finance and leasing+3 Latham & Watkins (sell-side)
Apr 2026 Jopari Solutions –Office AllyAcquisitionCompleted–Healthcare Software+1 TripleTreeKirkland & Ellis (buy-side)
Apr 2026 TriNetX –Regeneron PharmaceuticalsStakeCompleted–Healthcare Software+2 William Blair
Apr 2026 Dane Street ––StakeAnnounced–Healthcare Services+1 Latham & Watkins (sell-side)
Apr 2026 Staritas ECRI–DemergerAnnounced–Healthcare Software+1 Kirkland & Ellis
Apr 2026 Peachy –Stride Conumer PartnersStakeAnnounced–Medical Aesthetics+2 Raymond JamesLatham & Watkins (buy-side)
Apr 2026 Amplitude Vascular Systems –StrykerAcquisitionCompleted835.0Medtech+1 Perella Weinberg Partners (sell-side)
Apr 2026 Modersys (fka SmartFactory Rx) Applied MaterialsTELEO CapitalAsset saleCompleted–Industrial Software+1 Lazard
Apr 2026 Celerion H.I.G. Capital affiliateTHL PartnersAcquisitionAnnounced–Pharma Services+2 LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side)
Mar 2026 Apellis Pharmaceuticals –BiogenAcquisitionAnnounced5,600.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)WilmerHale (sell-side)Cravath, Swaine & Moore (buy-side)
Mar 2026 Centessa Pharmaceuticals –Eli Lilly and CompanySchemePending6,300.0Biotech+1 Centerview Partners (sell-side)Jefferies (sell-side)Goodwin (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)
Mar 2026 Vital Data Technology –MedReviewAcquisitionCompleted–Healthcare Software+2 Bailey & Company (sell-side)Sheppard, Mullin, Richter & Hampton (sell-side)Synergy Advisors (buy-side)Goodwin (buy-side)
Mar 2026 Majestic Medical Solutions –Radon Medical ImagingAcquisitionCompleted–Healthcare Services DLA Piper (buy-side)
Mar 2026 Kezar Life Sciences –Aurinia PharmaceuticalsAcquisitionAnnounced51.5Biotech+1 TD Securities (sell-side)Cooley (sell-side)
Mar 2026 AnaptysBio outstanding common stock –AnaptysBioBuy-backAnnounced100.0Biotech+1 Piper Sandler (buy-side)
Mar 2026 HealthTech Solutions –Health Management AssociatesAcquisitionAnnounced–Healthcare Software+1 Synergy Advisors (sell-side)
Mar 2026 Eos SENOLYTIX –PulmatrixMergerAnnounced–Biotech+1 Palladium Capital Group (buy-side)Evolution Venture Partners (sell-side)Wilk Auslander (sell-side)Gemini Valuation Services (buy-side)Haynes Boone (buy-side)
Mar 2026 Ouro Medicines –GileadAcquisitionAnnounced1,675.0Biotech+1 Paul, WeissGoodwin (sell-side)Centerview Partners (buy-side)
Mar 2026 Terns Pharmaceuticals –Merck & Co.AcquisitionAnnounced6,700.0Biotech+2 Centerview Partners (sell-side)Freshfields (sell-side)Jefferies (sell-side)Covington & Burling (buy-side)Gibson Dunn (buy-side)
Mar 2026 Syntegon CVC Capital PartnersApolloStakeAnnounced–Manufacturing+2 Willkie Farr & Gallagher (sell-side)Sidley Austin (buy-side)
Mar 2026 EyeSouth Partners’ retina business EyeSouth PartnersCencoraAsset saleAnnounced1,100.0Healthcare Services+1 Jefferies (sell-side)Kirkland & Ellis (sell-side)BofA Securities (buy-side)Citi (buy-side)Sidley Austin (buy-side)
Mar 2026 Pikavation SynnovationNovartisAcquisitionAnnounced2,000.0Biotech+2 Goodwin (sell-side)Centerview Partners (sell-side)
Mar 2026 DME Express WayPoint Capital PartnersPalladium Equity PartnersAcquisitionCompleted–Healthcare Services+1 KeyBanc Capital Markets (sell-side)Holland & Knight (sell-side)Katten Muchin Rosenman (sell-side)Edgemont Partners (buy-side)Morrison & Foerster (buy-side)
Mar 2026 AZSTARYS business Corium Therapeutics HoldingsCollegium PharmaceuticalAsset salePending650.0Pharma Centerview Partners (sell-side)Sullivan & Cromwell (sell-side)Leerink Partners (buy-side)Goodwin (buy-side)
Mar 2026 Owen Mumford Holdings –Embecta Corp.AcquisitionPending132.2Medtech+1 Forvis Mazars (South Africa) (sell-side)Mills & Reeve (sell-side)J.P. Morgan (buy-side)A&O Shearman (buy-side)
Mar 2026 Golden Rule Hospice –James River Home HealthAcquisitionCompleted–Healthcare Services The Braff Group (sell-side)
Mar 2026 Stratis Group –Nexus HealthAcquisitionAnnounced–Accounting, legal and consulting+1 Clearsight Advisors (sell-side)Pillsbury Winthrop Shaw Pittman (sell-side)
Mar 2026 The Physical Therapy and Rehabilitation Center –SportsMed Physical TherapyAcquisitionAnnounced–Healthcare Services Holland & Knight (buy-side)
Mar 2026 MedCare Express –AMKY Health CTAcquisitionAnnounced–Healthcare Services+1 Osage Advisors (sell-side)
Mar 2026 Asian Egg Bank –CSG.BIOAcquisitionCompleted–Healthcare Services Provident Healthcare Partners (sell-side)Nixon Peabody (sell-side)Venable (buy-side)
Mar 2026 A Caring Experience Nursing Services –HouseWorks HoldingsAcquisitionAnnounced–Healthcare Services+1 Provident Healthcare Partners (sell-side)Nixon Peabody (sell-side)Goodwin (buy-side)Reed Smith (buy-side)
Mar 2026 Selectis Health –Black Pearl EquitiesAcquisitionAnnounced–Aged Care+1 Pearson Butler (sell-side)Houlihan Valuation Advisors (sell-side)Olshan Frome Wolosky (buy-side)Laurel Hill Advisory Group (buy-side)
Mar 2026 Mytonomy –ElsevierAcquisitionCompleted–Healthcare Software Perella Weinberg Partners (sell-side)Cravath, Swaine & Moore (buy-side)
Mar 2026 Biocare Medical –Agilent TechnologiesAcquisitionAnnounced950.0Diagnostics+1 Sullivan & Cromwell (buy-side)
Mar 2026 Covenant Home Health –Residential Home HealthAcquisitionCompleted–Healthcare Services
Mar 2026 Talkspace –Universal Health ServicesAcquisitionAnnounced835.0Behavioral Health Wells Fargo Securities (sell-side)Cravath, Swaine & Moore (sell-side)J.P. Morgan (buy-side)McDermott Will & Schulte (buy-side)Stevens & Lee (buy-side)
Mar 2026 Roger Williams Medical Center and Our Lady of Fatima Hospital Prospect Medical HoldingsCenturion FoundationAcquisitionCompleted–Healthcare Services Hall, Render, Killian, Heath & Lyman (buy-side)
Mar 2026 Lisata Therapeutics –Kuva LabsAcquisitionPending–Biotech+2 Mintz (sell-side)H.C. Wainwright & Co. (sell-side)Goodwin (buy-side)Campaign Management (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built